Outcomes	O

The	O
primary	O
endpoint	O
was	O
time	B-PrimaryOutcome
to	I-PrimaryOutcome
achieve	I-PrimaryOutcome
a	I-PrimaryOutcome
negative	I-PrimaryOutcome
RT	I-PrimaryOutcome
-	I-PrimaryOutcome
PCR	I-PrimaryOutcome
result	I-PrimaryOutcome
for	I-PrimaryOutcome
SARS	I-PrimaryOutcome
-	I-PrimaryOutcome
CoV	I-PrimaryOutcome
-	I-PrimaryOutcome
2	I-PrimaryOutcome
in	I-PrimaryOutcome
a	I-PrimaryOutcome
nasopharyngeal	I-PrimaryOutcome
swab	I-PrimaryOutcome
sample	I-PrimaryOutcome
.	O

Secondary	O
clinical	O
endpoints	O
were	O
time	B-SecondaryOutcome
to	I-SecondaryOutcome
resolution	I-SecondaryOutcome
of	I-SecondaryOutcome
symptoms	I-SecondaryOutcome
defined	O
as	O
a	B-OutcomeDefinition
NEWS2	I-OutcomeDefinition
of	I-OutcomeDefinition
0	I-OutcomeDefinition
maintained	I-OutcomeDefinition
for	I-OutcomeDefinition
24	I-OutcomeDefinition
h	I-OutcomeDefinition
;	O
daily	B-TimeFrame
NEWS2	B-SecondaryOutcome
and	I-SecondaryOutcome
sequential	I-SecondaryOutcome
organ	I-SecondaryOutcome
failure	I-SecondaryOutcome
assessment	I-SecondaryOutcome
(	I-SecondaryOutcome
SOFA	I-SecondaryOutcome
)	I-SecondaryOutcome
score	I-SecondaryOutcome
;	O
length	B-SecondaryOutcome
of	I-SecondaryOutcome
hospital	I-SecondaryOutcome
stay	I-SecondaryOutcome
;	O
and	O
30	B-TimeFrame
-	I-TimeFrame
day	I-TimeFrame
mortality	B-SecondaryOutcome
.	O

Other	O
virological	O
endpoints	O
included	O
the	O
time	B-OtherOutcome
to	I-OtherOutcome
achieve	I-OtherOutcome
negative	I-OtherOutcome
SARS	I-OtherOutcome
-	I-OtherOutcome
CoV	I-OtherOutcome
-	I-OtherOutcome
2	I-OtherOutcome
RT	I-OtherOutcome
-	I-OtherOutcome
PCR	I-OtherOutcome
in	I-OtherOutcome
all	I-OtherOutcome
clinical	I-OtherOutcome
samples	I-OtherOutcome
,	O
including	O
nasopharyngeal	B-OutcomeDefinition
swab	I-OutcomeDefinition
,	I-OutcomeDefinition
posterior	I-OutcomeDefinition
oropharyngeal	I-OutcomeDefinition
saliva	I-OutcomeDefinition
,	I-OutcomeDefinition
throat	I-OutcomeDefinition
swab	I-OutcomeDefinition
,	I-OutcomeDefinition
stool	I-OutcomeDefinition
,	I-OutcomeDefinition
and	I-OutcomeDefinition
urine	I-OutcomeDefinition
;	O
daily	B-OtherOutcome
viral	I-OtherOutcome
load	I-OtherOutcome
changes	I-OtherOutcome
in	B-TimeFrame
the	I-TimeFrame
first	I-TimeFrame
7	I-TimeFrame
days	I-TimeFrame
;	O
and	O
emergence	B-OtherOutcome
of	I-OtherOutcome
amino	I-OtherOutcome
acid	I-OtherOutcome
mutations	I-OtherOutcome
in	I-OtherOutcome
the	I-OtherOutcome
nsp5	I-OtherOutcome
gene	I-OtherOutcome
encoding	I-OtherOutcome
a	I-OtherOutcome
3C	I-OtherOutcome
-	I-OtherOutcome
like	I-OtherOutcome
protease	I-OtherOutcome
.	O

The	O
serum	B-OtherOutcome
cytokine	I-OtherOutcome
response	I-OtherOutcome
was	O
also	O
measured	O
.	O

Safety	O
endpoints	O
were	O
the	O
frequencies	B-OtherOutcome
and	I-OtherOutcome
duration	I-OtherOutcome
of	I-OtherOutcome
adverse	I-OtherOutcome
events	I-OtherOutcome

